Laboratory Of America Holdings Profit Margins 2006-2018 | LH

Current and historical gross, operating and net profit margins for Laboratory Of America Holdings (LH) over the last 10 years. The current net profit margin for Laboratory Of America Holdings (LH) as of March 31, 2018 is 11.52%.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.027B $10.441B
Laboratory Corporation of America Holdings is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.
Stock Name Country Market Cap PE Ratio
Becton, Dickinson (BDX) United States $66.007B 24.73
Align Technology (ALGN) United States $30.087B 88.95
McKesson (MCK) United States $26.816B 10.51
AmerisourceBergen (ABC) United States $18.617B 13.55
Cardinal Health (CAH) United States $15.161B 9.57
Cooper (COO) United States $12.206B 22.72
Henry Schein (HSIC) United States $11.600B 20.55
DENTSPLY SIRONA (XRAY) United States $10.242B 17.19
West Pharmaceutical Services (WST) United States $7.329B 40.82
Merit Medical Systems (MMSI) United States $2.813B 42.27
Patterson (PDCO) United States $2.239B 14.07
CONMED (CNMD) United States $2.059B 35.82
STAAR Surgical (STAA) United States $1.411B 484.29
Atrion (ATRI) United States $1.167B 33.32
Invacare (IVC) United States $0.695B 0.00
Endologix (ELGX) United States $0.445B 0.00
Antares Pharma (ATRS) United States $0.436B 0.00
Lifevantage (LFVN) United States $0.140B 29.06
Aceto (ACET) United States $0.099B 4.04
Milestone Scientific (MLSS) United States $0.030B 0.00
Pro-Dex (PDEX) United States $0.029B 12.95
Biolase (BIOL) United States $0.028B 0.00
Retractable Technologies (RVP) United States $0.027B 0.00